On April 14, Diana Shipping issued an open letter to Genco shareholders criticizing the board's refusal to engage in an all-cash, premium takeover offer. On the same day, Genco Shipping & Trading issued a formal statement in response to Diana's letter. Additionally, CollPlant announced the termination of its development agreement with AbbVie.
Fifty 1 Labs (OTC: FITY) has announced a strategic expansion of its biotechnology operations, specifically targeting the development of peptide products for musculoskeletal (MSK) health. The company is leveraging an advanced AI-enabled platform to accelerate peptide discovery and clinical development for tissue…
Read the full storyImageneBio has announced a $30 million private placement aimed at advancing its therapeutics for immunological diseases. The company plans to utilize the proceeds to accelerate the development of its IMG-007 drug candidate for treating alopecia areata and atopic dermatitis. Simultaneously, Spartan Metals Corp has…
Tensions in the maritime sector escalated as Diana Shipping issued an open letter to Genco Shipping & Trading shareholders, criticizing the board's refusal to engage on an all-cash, premium takeover offer. Genco responded with a formal statement defending its position, signaling a potential hostile takeover battle…